Abstract:Imidazole alkaloids, a common class of five-membered aromatic heterocyclic compounds, exist widely in plants, animals and marine organisms. Because of imidazole's extensive and excellent biological and pharmacological activities, it has always been a topic of major interest for researchers and has been widely used as an active moiety in search of bioactive molecules. To find more efficient antibacterial compounds, a series of novel imidazole-fragment-decorated 2-(pyrazol-4-yl)-1,3,4-oxadiazoles were designed and synthesized based on our previous works via the active substructure splicing principle, and their bioactivities were systematically evaluated both in vitro and in vivo. The bioassays showed that some of the target compounds displayed excellent in vitro antibacterial activity toward three virulent phytopathogenic bacteria, including Xanthomonas oryzae pv. oryzae (Xoo), Xanthomonas axonopodis pv. citri (Xac) and Pseudomonas syringae pv. actinidiae (Psa), affording the lowest EC50 values of 7.40 (7c), 5.44 (9a) and 12.85 (9a) μg/mL, respectively. Meanwhile, compound 7c possessed good in vivo protective and curative activities to manage rice bacterial leaf blight at 200 μg/mL, with control efficacies of 47.34% and 41.18%, respectively. Furthermore, compound 9a showed commendable in vivo protective and curative activities to manage kiwifruit bacterial canker at 200 μg/mL, with control efficacies of 46.05% and 32.89%, respectively, which were much better than those of the commercial bactericide TC (31.58% and 17.11%, respectively). In addition, the antibacterial mechanism suggested that these new types of title compounds could negatively impact the cell membranes of phytopathogenic bacteria cells and cause the leakage of the intracellular component, thereby leading to the killing of bacteria. All these findings confirm that novel 2-(pyrazol-4-yl)-1,3,4-oxadiazoles containing an imidazole fragment are promising lead compounds for discovering new bactericidal agents.

Synthesis of Novel 1,3,4-Oxadiazole Derivatives Containing Diamides As Promising Antibacterial and Antiviral Agents

Synthesis and Antibacterial Evaluation of Novel 1,3,4-Oxadiazole Derivatives Containing Sulfonate/Carboxylate Moiety.

Synthesis and Biological of Novel Myricetin Derivatives Containing 1,3,4-Oxadiazoles

Synthesis and Bioactivities of 1-Aryl-4-hydroxy-1h-pyrrol-2(5h)-one Derivatives Bearing 1,3,4-Oxadiazole Moiety

Antiviral and Antibacterial Activities of N‐(4‐Substituted Phenyl) Acetamide Derivatives Bearing 1,3,4‐oxadiazole Moiety

Design, Synthesis, and Biological Activity of Novel Myricetin Derivatives Containing Amide, Thioether, and 1,3,4-Thiadiazole Moieties

Antibacterial and Antiviral Activities of 1,3,4-Oxadiazole Thioether 4H-Chromen-4-one Derivatives.

Synthesis and Biological Activity of Myricetin Derivatives Containing 1,3,4-Thiadiazole Scaffold

Novel 1,3,4-Oxadiazole Thioether and Sulfone Derivatives Bearing a Flexible N-Heterocyclic Moiety: Synthesis, Characterization, and Anti-microorganism Activity

Design and Synthesis of Novel 1,3,4-Oxadiazole Sulfone Compounds Containing 3,4-Dichloroisothiazolylamide Moiety and Evaluation of Rice Bacterial Activity.

Design, Synthesis, and Evaluation of New Sulfone Derivatives Containing a 1,3,4-Oxadiazole Moiety As Active Antibacterial Agents.

Synthesis and Biological Activity of 1,4-Pentadien-3-one Derivatives Containing Triazine Scaffolds

Synthesis, antiviral and antibacterial activities and action mechanism of penta-1,4-dien-3-one oxime ether derivatives containing a quinoxaline moiety

Design, Synthesis, and Biological Activity of Novel 1,2,4-Oxadiazole Derivatives

Design, Synthesis, and Antimicrobial Behavior of Novel Oxadiazoles Containing Various N-containing Heterocyclic Pendants

Novel Phosphorylated Penta-1,4-Dien-3-One Derivatives: Design, Synthesis, And Biological Activity

Design, Synthesis, and Bioactivity Evaluation of Novel 1,3,4-Thiadiazole Sulfone-Derived Compounds Incorporating an Amide Moiety as Active Antibacterial Agents

Synthesis and Bioactivities of Novel 2-(Thioether/sulfone)-5-pyrazolyl-1,3,4-oxadiazole Derivatives

Design, Synthesis and Bioactivity Evaluation of Novel 2-(pyrazol-4-yl)-1,3,4-oxadiazoles Containing an Imidazole Fragment as Antibacterial Agents

Novel quinazolin-4(3H)-one derivatives containing a 1,3,4-oxadiazole thioether moiety as potential bactericides and fungicides: Design, synthesis, characterization and 3D-QSAR analysis

Discovery of Novel Bis-Sulfoxide Derivatives Bearing Acylhydrazone and Benzothiazole Moieties As Potential Antibacterial Agents